DE69330031D1 - Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment - Google Patents

Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment

Info

Publication number
DE69330031D1
DE69330031D1 DE69330031T DE69330031T DE69330031D1 DE 69330031 D1 DE69330031 D1 DE 69330031D1 DE 69330031 T DE69330031 T DE 69330031T DE 69330031 T DE69330031 T DE 69330031T DE 69330031 D1 DE69330031 D1 DE 69330031D1
Authority
DE
Germany
Prior art keywords
antibody
fhv
recombinant antibody
feline herpesvirus
gene fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330031T
Other languages
English (en)
Other versions
DE69330031T2 (de
DE565478T1 (de
Inventor
Kazuhiko Kimachi
Hiroaki Maeda
Kiyoto Nishiyama
Sachio Tokiyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE69330031D1 publication Critical patent/DE69330031D1/de
Publication of DE69330031T2 publication Critical patent/DE69330031T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/801—Drug, bio-affecting and body treating compositions involving antibody or fragment thereof produced by recombinant dna technology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69330031T 1992-11-28 1993-11-25 Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment Expired - Fee Related DE69330031T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34125592A JP3919830B2 (ja) 1992-11-28 1992-11-28 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
PCT/JP1993/001724 WO1994012661A1 (en) 1992-11-28 1993-11-25 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody

Publications (2)

Publication Number Publication Date
DE69330031D1 true DE69330031D1 (de) 2001-04-19
DE69330031T2 DE69330031T2 (de) 2001-07-19

Family

ID=18344623

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330031T Expired - Fee Related DE69330031T2 (de) 1992-11-28 1993-11-25 Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment

Country Status (9)

Country Link
US (1) US5760185A (de)
EP (1) EP0671472B1 (de)
JP (1) JP3919830B2 (de)
AT (1) ATE199745T1 (de)
AU (1) AU674043B2 (de)
CA (1) CA2150346C (de)
DE (1) DE69330031T2 (de)
ES (1) ES2160115T3 (de)
WO (1) WO1994012661A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1441766B1 (de) * 2001-10-16 2011-09-14 MacroGenics West, Inc. An das krebsassoziierte antigen cd46 bindende antikörper und verwendungsverfahren dafür
BRPI0214188B8 (pt) 2001-11-08 2021-05-25 Beijing Wantai Biological Pharmacy Entpr Co Ltd anticorpo ou fragmento do mesmo, molécula de ácido nucléico, uso do anticorpo monoclonal ou fragmento do mesmo, kit de diagnóstico, composição farmacêutica, vetor de expressão recombinante, célula hospedeira transformada com o vetor de expressão recombinante e método para detectar o antígeno do vírus da hepatite e ou o anticorpo contra o vírus da hepatite e em uma amostra
US7405061B2 (en) * 2002-11-13 2008-07-29 Raven Biotechnologies, Inc. Antigen PIPA and antibodies that bind thereto
JP5372500B2 (ja) 2005-06-17 2013-12-18 トレラクス リクイデーティング トラスト Ｉｌｔ３結合分子およびその使用
EP2041180B8 (de) 2006-06-19 2014-03-05 Liquidating Trust Ilt3-bindende moleküle und verwendungen davon
RS55740B1 (sr) 2006-10-02 2017-07-31 Squibb & Sons Inc Humana antitela koja se vezuju za cxcr4 i njihove upotrebe
ES2678060T3 (es) 2006-12-01 2018-08-08 E. R. Squibb & Sons, L.L.C. Anticuerpos, en particular, anticuerpos humanos, que se unen a CD22 y usos de los mismos
CL2007003622A1 (es) 2006-12-13 2009-08-07 Medarex Inc Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
KR20090088946A (ko) 2006-12-14 2009-08-20 메다렉스, 인코포레이티드 씨디70에 결합하는 인간 항체 및 이의 용도
AU2009218069B2 (en) 2008-02-27 2014-05-01 Fuso Pharmaceutical Industries, Ltd. Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
KR101655492B1 (ko) 2008-12-22 2016-09-07 국립대학법인 홋가이도 다이가쿠 동물세포를 사용해서 외래유전자 유래 단백질을 대량으로 생산하기 위한 발현 벡터, 및 그의 이용
BR112012022342A2 (pt) * 2010-03-04 2017-02-14 Vet Therapeutics Inc anticorpos monoclonais dirigidos a cd52
BR112012022338A2 (pt) * 2010-03-04 2017-02-14 Vet Therapeutics Inc anticorpos monoclonais direcionados a cd20
US9616120B2 (en) 2010-03-04 2017-04-11 Vet Therapeutics, Inc. Monoclonal antibodies directed to CD20
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
AR091649A1 (es) 2012-07-02 2015-02-18 Bristol Myers Squibb Co Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
EP2983711A4 (de) * 2013-04-08 2016-11-23 Cytodyn Inc Felinisierte antikörper und verfahren zur behandlung von retrovireninfektionen bei katzen
WO2018089335A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
US10093731B2 (en) 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
US12060437B2 (en) 2018-03-23 2024-08-13 North Carolina State University Methods and compositions for antibody to high affinity receptor for IgE
AU2019273200B2 (en) 2018-05-24 2024-10-31 Fuso Pharmaceutical Industries,Ltd. Novel vector and use thereof
KR20210040827A (ko) 2018-07-25 2021-04-14 이노벤트 바이오로직스 (쑤저우) 컴퍼니, 리미티드 항 tigit 항체 및 그 용도
CN109762067B (zh) 2019-01-17 2020-02-28 北京天广实生物技术股份有限公司 结合人Claudin 18.2的抗体及其用途
AU2021228061A1 (en) 2020-02-27 2022-10-13 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antibodies binding IL4R and uses thereof
EP4151654A1 (de) 2020-05-12 2023-03-22 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. St2-antigenbindendes protein
WO2023093816A1 (zh) 2021-11-25 2023-06-01 诺纳生物（苏州）有限公司 抗Siglec-15抗体及其应用
AU2022446336A1 (en) 2022-03-18 2024-09-19 Beijing Mabworks Biotech Co., Ltd B7-h3-binding antibody and use thereof
CN115850453B (zh) * 2022-12-16 2024-09-10 北京纳百生物科技有限公司 针对猫疱疹病毒1型gD蛋白的特异性抗体及用途
CN116284350B (zh) * 2023-05-06 2023-08-04 泰州博莱得利生物科技有限公司 一种猫疱疹病毒单克隆抗体及其制备方法和应用
CN117607431B (zh) * 2023-06-30 2024-10-25 深圳赫兹生命科学技术有限公司 猫疱疹病毒的elisa检测试剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH01309785A (ja) 1988-06-06 1989-12-14 Babcock Hitachi Kk ミドルパルスｔｉｇ溶接装置
JP2811086B2 (ja) * 1989-08-10 1998-10-15 財団法人化学及血清療法研究所 ネコ×マウスヘテロハイブリドーマおよびネコ免疫グロブリンλ鎖の定常領域をコードする遺伝子断片
JP2811095B2 (ja) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンκ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
AU632843B2 (en) * 1989-08-10 1993-01-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
JP2811102B2 (ja) * 1989-12-28 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
JPH03123486A (ja) * 1989-10-06 1991-05-27 Hitachi Ltd 膜蛋白質の遺伝子工学的生産方法

Also Published As

Publication number Publication date
DE69330031T2 (de) 2001-07-19
EP0671472B1 (de) 2001-03-14
CA2150346A1 (en) 1994-06-09
WO1994012661A1 (en) 1994-06-09
CA2150346C (en) 2005-08-09
EP0671472A1 (de) 1995-09-13
AU674043B2 (en) 1996-12-05
US5760185A (en) 1998-06-02
JPH06217786A (ja) 1994-08-09
JP3919830B2 (ja) 2007-05-30
EP0671472A4 (de) 1997-11-19
ES2160115T3 (es) 2001-11-01
ATE199745T1 (de) 2001-03-15
AU5596194A (en) 1994-06-22

Similar Documents

Publication Publication Date Title
DE69330031D1 (de) Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment
EP1244708B8 (de) Verfahren zur behandlung von entzündungen
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
EP1329518A3 (de) Sonde zur Diagnose einer ansteckenden Krankheit verursacht durch Staphylococcus aureus
DE69532333T2 (de) Pestizid-proteine und stämme
ATE340590T1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
EP0871703A4 (de) Dna kodierend für glutaminsäure-bewachte chloridkanäle
ES2127189T3 (es) Peptido nuevo biologicamente activo procedente de una rana (rana-cpn).
ATE276276T1 (de) Rekombinanter anti-hiv antikörper und seine herstellung
EP0837931A4 (de) Methode zur expression in und isolation von biologisch aktiven molekülen aus urin
EP0184575A3 (en) Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
PT85093A (fr) Vecteur viral et procede de preparation de adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a.
DE69328799D1 (de) Anti-Felincalicivirus rekombinanter Antikörper und dafür kodierendes Gen
EP0648841A3 (de) Genomische DNS für menschliche Cholesterol-7-alpha Hydroxylase und Verfahren dessen Verwendung.
DE59611293D1 (de) Protein mit dnase-aktivität
AR001321A1 (es) Toxinas noveles.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee